Cinacalcet Tablet
Product Images NDC 71335-2762

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 71335-2762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 01)

Chemical structure of cinacalcet hydrochloride, showing its molecular framework with a trifluoromethyl-substituted phenyl ring, an amine group, and a naphthyl moiety linked through a methyl-substituted chiral center.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 02)

A line chart comparing PTH (pg/mL) levels over 26 weeks between placebo and cinacalcet tablets. The x-axis represents weeks, and the y-axis shows PTH concentration. The chart includes error bars and demonstrates a decrease in PTH levels with cinacalcet tablets compared to stable or slightly increasing levels with placebo.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 03)

A line graph comparing serum calcium phosphate (Ca x P) levels over 26 weeks between placebo and Cinacalcet tablets groups. The x-axis represents weeks from 0 to 26, and the y-axis shows Ca x P levels in mg/dL. The Cinacalcet group shows a notable decrease followed by stabilization, while the placebo group maintains higher levels with minor variation.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 04)

A line graph depicting calcium levels (mg/dL) over weeks in a clinical study. The x-axis shows time from baseline through titration and maintenance phases, while the y-axis shows calcium concentration. Data points include error bars representing variability, with a sample size noted for parathyroid carcinoma patients.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 05)

A line graph showing changes in serum calcium levels (mg/dL) over time in weeks, with data points indicating mean values and error bars. The x-axis represents weeks from titration through maintenance, and the y-axis represents calcium concentration levels. The graph includes annotations for titration and maintenance phases and the number of intractable pHPT cases at each time point.*

FDA Label Image

Label (Lbl713352762)

This label is for Cinacalcet Tablets 60 mg, containing film-coated tablets with 66 mg Cinacalcet Hydrochloride equivalent to 60 mg Cinacalcet. The package contains 30 tablets. It is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Cipla Ltd. Storage instructions and QR codes for dosage information and package insert are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.